相关实验视频
Updated: Jun 25, 2026

Experimental Human Pneumococcal Carriage
Published on: February 15, 2013
使用人类挑战模型 (CHIPS) 确定最低的青素度以预防因Streptococcus pyogenes引起的喉炎:一种随机,双盲,安慰剂控制的随机试验
Thel K Hla1, Joshua Osowicki2, Julie A Marsh3
1Wesfarmers Centre for Vaccines and Infectious Diseases, Telethon Kids Institute, Nedlands, WA, Australia; Medical School, University of Western Australia, Crawley, WA, Australia; Department of Infectious Diseases, Fiona Stanley Hospital, WA, Australia.
预防Streptococcus pyogenes 喉炎需要至少8.1 ng/mL的青素血度. 这一发现有助于优化青素剂量,以预防风湿性心脏病.
科学领域:
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
- 临床试验 临床试验
背景情况:
- 预防Streptococcus pyogenes喉炎和随后的风湿性心脏病所需的精确青素血度仍然未知.
- 使用人类挑战模型来确定预防 estreptococcal 喉炎的最小有效度.
研究的目的:
- 为了确定预防实验性Streptococcus pyogenes 喉炎所需的最小青素血度.
- 为改善长效青素配方和用于风湿性发烧和风湿性心脏病预防的剂量方案的开发提供信息.
主要方法:
- 一个随机,双盲,安慰剂控制的人类挑战试验 (CHIPS) 涉及健康的成年志愿者.
- 参与者接受了连续的静脉注射青素输液,以达到目标稳定状态血度,范围从0到20 ng/mL.
- 随着对emm75 S. pyogenes菌株的喉暴露,临床喉炎的评估作为主要终点.
主要成果:
- 参与者的青素度为9 ng/mL或更高的参与者没有发生喉炎.
- 贝叶斯模型表明,最低稳定状态青素血度为8.1 ng/mL (95%可信区间为6.1-10.9 ng/mL),对喉炎的保护率为90%.
- 在试验期间没有报告任何严重不良事件.
结论:
- 超过9 ng/mL的青素度有效防止实验性emm75 S. pyogenes 喉炎.
- 这些发现为优化青素治疗策略提供了关键数据,以预防复发性类风湿性发烧和类风湿性心脏病.
更多相关视频
16:56Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections
Published on: August 30, 2014
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
相关概念视频
Acute Pharyngitis
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
Production of Antibiotics
Streptococcal Pharyngitis